Peripheral immune-inducer dendritic cells drive early-life allergic inflammation
- Article
- Published: 25 February 2026
Peripheral immune-inducer dendritic cells drive early-life allergic inflammation
- Yue Xing
orcid.org/0000-0001-5845-22861,
- Ilana Reznikov1,
- Abonti Nur Ahmed1,
- Ikjot Sidhu
orcid.org/0000-0002-1470-64211,
- Jill Wisnewski
orcid.org/0000-0003-2976-32312,
- Asma Farhat1,
- Aleksandr Prystupa1,
- Piotr Konieczny
orcid.org/0000-0003-4114-349X3,
- Kody Mansfield4,
- Melissa L. Cooper
orcid.org/0000-0003-4337-83565,
- Stephen T. Yeung
orcid.org/0000-0002-9710-55676,
- Madeline Kim7,
- Sophia Adeghe8,
- Katherine D. Gaines
orcid.org/0009-0005-8038-88701,
- Meredith Manson7,
- Ji Hyun Sim9,10,
- Qingrong Huang
orcid.org/0000-0002-7692-516011,
- Ata S. Moshiri
orcid.org/0000-0001-6684-450312,
- Kamal M. Khanna
orcid.org/0000-0002-9328-381713,14,
- Theresa T. Lu
orcid.org/0000-0002-5707-87449,10,
- Emma Guttman-Yassky
orcid.org/0000-0002-9363-324X7,
- Amanda W. Lund
orcid.org/0000-0001-7389-998312,13,15,
- Niroshana Anandasabapathy8,16 &
- …
- Shruti Naik
orcid.org/0000-0002-2216-51351,7
Nature
(2026)Cite this article
4266 Accesses
84 Altmetric
Metrics
Subjects
- Acute inflammation
- Conventional dendritic cells
Abstract
Atopic diseases associated with allergens, as well as allergic diseases, frequently arise early in life; however, the age-dependent mechanisms governing immune responses to allergens remain poorly understood1. Here we find that in early life, exposure to common allergens triggers a distinct bifurcated immune response, simultaneously triggering type 17 inflammation in the skin and initiating canonical T helper 2 sensitization in the lymph nodes. This early-life γδ type 17-mediated dermatitis primes the exaggerated allergic lung inflammation upon secondary allergen exposure. Mechanistically, we find dendritic cell (DC)-mediated type 17 activation directly in the skin without requiring migration to lymph nodes; we term this state ‘peripheral immune inducer’ (pii) DC. CD301b+ conventional type 2 DCs acquire allergen, adopt the pii-DC state, produce IL-23 and activate local γδ type 17 cells independently of lymph-node engagement. The pii-DC state is enabled by the immature hypothalamic–pituitary–adrenal axis and physiologically low systemic glucocorticoids characteristic of early life2,3; DC-specific deletion of the glucocorticoid receptor recapitulates the pii-DC phenotype. These findings define a developmental checkpoint, set by neuroendocrine maturation, that enables in situ DC activation and immune induction, thereby shaping age-dependent responses to allergens.
Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Fig. 1: Heightened immune sensitivity to common allergens in early life.
Fig. 2: Type 17 immunity drives early-life responses to HDM.
Fig. 3: pii-DCs trigger HDM skin inflammation in early life.
Fig. 4: pii-cDC2-derived IL-23 activates γδ T17 cells directly in pup skin after HDM exposure.
Fig. 5: Developing HPA and low systemic corticosterone levels in early life enable the pii-DC state.
Similar content being viewed by others
Article
18 November 2021